| Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance A Visvanathan, V Patil, A Arora, AS Hegde, A Arivazhagan, V Santosh, ... Oncogene 37 (4), 522-533, 2018 | 517 | 2018 |
| Glioblastoma vs temozolomide: can the red queen race be won? A Arora, K Somasundaram Cancer biology & therapy 20 (8), 1083-1090, 2019 | 93 | 2019 |
| Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma A Arora, V Patil, P Kundu, P Kondaiah, AS Hegde, A Arivazhagan, ... Scientific reports 9 (1), 2749, 2019 | 42 | 2019 |
| Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP/TAZ-dependent transcription Z Nawaz, V Patil, A Arora, AS Hegde, A Arivazhagan, V Santosh, ... Scientific reports 6 (1), 27753, 2016 | 38 | 2016 |
| Single cell RNA‐sequencing: A powerful yet still challenging technology to study cellular heterogeneity M Ke, B Elshenawy, H Sheldon, A Arora, FM Buffa Bioessays 44 (11), 2200084, 2022 | 36 | 2022 |
| Targeted proteomics comes to the benchside and the bedside: is it ready for us? A Arora, K Somasundaram Bioessays 41 (2), 1800042, 2019 | 27 | 2019 |
| Pooled shRNA screen uncovered the role of SEL1L, an ERAD (endoplasmic reticulum associated degradation) gene, in modulating temozolomide resistance in GBM A Arora, VS Tomar, S Thomas, V Patil, J Hoheisel, K Somasundaram CANCER RESEARCH 78 (13, S), 2018 | 1 | 2018 |
| Metabolic symbiosis between oxygenated and hypoxic tumour cells: An agent-based modelling study PG Jayathilake, P Victori, CE Pavillet, CH Lee, D Voukantsis, A Miar, ... PLOS Computational Biology 20 (3), e1011944, 2024 | | 2024 |
| Chronic hypoxia in TNBC breast cancer induces development of a novel population of CD24+/CD49b-high cells characterized by high expression of CST1 MS Ke, B Elshenawy, A Arora, H Sheldon, A Harris, F Buffa CANCER RESEARCH 84 (3), 2024 | | 2024 |
| Abstract B056: Chronic hypoxia in TNBC breast cancer induces development of a novel population of CD24+/CD49b-high cells characterized by high expression of CST1 MS Ke, B Elshenawy, A Arora, H Sheldon, A Harris, F Buffa Cancer Research 84 (3_Supplement_1), B056-B056, 2024 | | 2024 |
| Improving Glioblastoma Management: A Study of Biomarkers, Tumor Microenvironment and Chemoresistance A Arora | | 2021 |
| Abstract LB-098: Pooled shRNA screen uncovered the role of SEL1L, an ERAD (endoplasmic reticulum associated degradation) gene, in modulating temozolomide resistance in GBM A Arora, VS Tomar, S Thomas, V Patil, J Hoheisel, K Somasundaram Cancer Research 78 (13_Supplement), LB-098-LB-098, 2018 | | 2018 |
| Glioblastoma vs temozolomide: can the red sovereign race shall achieved? A Arora, K Somasundaram | | |
